王雪颖, 袁维运, 周详, 黄瑶楠, 马静. 高同型半胱氨酸血症患者血液流变学和血脂水平的相关性研究[J]. 心脏杂志, 2022, 34(6): 659-662. DOI: 10.12125/j.chj.202201054
    引用本文: 王雪颖, 袁维运, 周详, 黄瑶楠, 马静. 高同型半胱氨酸血症患者血液流变学和血脂水平的相关性研究[J]. 心脏杂志, 2022, 34(6): 659-662. DOI: 10.12125/j.chj.202201054
    Xue-ying WANG, Wei-yun YUAN, Xiang ZHOU, Yao-nan HUANG, Jing MA. Correlation between hemorheology, blood lipid level and hyperhomocysteinemia[J]. Chinese Heart Journal, 2022, 34(6): 659-662. DOI: 10.12125/j.chj.202201054
    Citation: Xue-ying WANG, Wei-yun YUAN, Xiang ZHOU, Yao-nan HUANG, Jing MA. Correlation between hemorheology, blood lipid level and hyperhomocysteinemia[J]. Chinese Heart Journal, 2022, 34(6): 659-662. DOI: 10.12125/j.chj.202201054

    高同型半胱氨酸血症患者血液流变学和血脂水平的相关性研究

    Correlation between hemorheology, blood lipid level and hyperhomocysteinemia

    • 摘要:
        目的  探究血液流变学指标和血脂水平与高同型半胱氨酸血症(HHcy)患者的相关性。
        方法  选择2020年12月~2021年11月于本院就诊的高同型半胱氨酸血症患者共162例,另选取同期正常查体者309例为对照组,所有患者均检测血清同型半胱氨酸(Hcy)、血液流变学指标及血脂(甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇),并筛选其中检测后接受了叶酸和甲钴胺纠正治疗的患者27例,在其治疗一个月后再次检测相应指标,对比并分析结果。
        结果  HHcy组全血黏度切变率1、5、30、200 (mPa·s)、总胆固醇、甘油三酯、低密度脂蛋白胆固醇明显高于对照组,高密度脂蛋白胆固醇明显低于对照组,差异均有统计学意义(均P<0.05),多因素 Logistic 回归分析结果显示全血黏度切变率 1、5(mPa·s)(均P<0.05);甘油三酯、低密度脂蛋白胆固醇(均P<0.01)是HHcy的影响因素。通过叶酸与甲钴胺药物纠正治疗4周后进行复查,Hcy、全血黏度切变率 1、5(mPa·s)、甘油三酯、低密度脂蛋白胆固醇水平明显降低, 均P<0.05。
        结论  全血黏度切变率 1、5(mPa·s)、甘油三酯和低密度脂蛋白胆固醇是HHcy的影响因素;叶酸和甲钴胺药物治疗干预能降低Hcy水平,改善血液流变学参数 1、5(mPa·s)、甘油三酯与低密度脂蛋白胆固醇指标。

       

      Abstract:
        AIM   To study the correlation between hemorheology and blood lipid levels in patients with hyperhomocysteine (HHcy).
        METHODS  A total of 162 HHcy patients admitted to our hospital from December 2020 to November 2021 were selected for HHcy group and 309 subjects under routine physical examination during the same period served as control group. Serum homocysteine (hcy), hemorheology and blood lipid triglyceride, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol were detected in both groups. Twenty-seven patients who received folic acid and methcobalamin correction therapy were screened out, whose corresponding indicators were tested again a month after treatment, and the results were analyzed.
        RESULTS  The whole blood viscosity shear rates of 1,5,30,200 (mPa·s), total cholesterol, triglyceride and low density lipoprotein cholesterol in HHcy group were significantly higher than those in the control group, and high density lipoprotein cholesterol was significantly lower than those in the control group (all P<0.05). The results of multivariate logistic regression analysis showed that the whole blood viscosity shear rates of 1,5 (mPa·s) (all P<0.05); Triglyceride and low density lipoprotein cholesterol (all P<0.01) were the influencing factors of HHcy. After 4 weeks of corrective treatment with folic acid and Mecobalamin, the levels of Hcy, whole blood viscosity shear rate 1 and 5 (mPa·s), triglyceride and low density lipoprotein cholesterol decreased significantly (P<0.05).
        CONCLUSION  whole blood viscosity, shear rate 1,5 (mPa·s), triglyceride and low density lipoprotein cholesterol are the influencing factors of HHcy; Folic acid and Mecobalamin can reduce the level of Hcy and improve the indexes of hemorheological parameters 1,5 (mPa·s), triglyceride and low density lipoprotein cholesterol.

       

    /

    返回文章
    返回